Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shai Magidi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scientific Reports|July 14, 2026
OptiRanker: a simulation and optimization framework for efficient in vivo validation of drug prioritization algorithmsOhad Landau, Kartheeswaran Thangathurai, Shai Magidi, et al.
Oncotarget|June 17, 2025
Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatmentAlberto Hernando-Calvo, Razelle Kurzrock, Nadia Saoudi Gonzalez, et al.
The Journal of Investigative Dermatology|April 17, 2018
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in BloodTali Czarnowicki, Helen He, Alexandra Leonard, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.
NPJ Precision Oncology|April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survivalVladimir Lazar, Shai Magidi, Nicolas Girard, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lungVladimir Lazar, Jacques Raynaud, Shai Magidi, et al.
JCO Precision Oncology|September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant TherapiesVladimir Lazar, Nicolas Girard, Eric Raymond, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 14, 2026
OptiRanker: a simulation and optimization framework for efficient in vivo validation of drug prioritization algorithmsOhad Landau, Kartheeswaran Thangathurai, Shai Magidi, et al.
Oncotarget|June 17, 2025
Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatmentAlberto Hernando-Calvo, Razelle Kurzrock, Nadia Saoudi Gonzalez, et al.
The Journal of Investigative Dermatology|April 17, 2018
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in BloodTali Czarnowicki, Helen He, Alexandra Leonard, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.
NPJ Precision Oncology|April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survivalVladimir Lazar, Shai Magidi, Nicolas Girard, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lungVladimir Lazar, Jacques Raynaud, Shai Magidi, et al.
JCO Precision Oncology|September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant TherapiesVladimir Lazar, Nicolas Girard, Eric Raymond, et al.
Pageof 2